The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Sullivan Lara since 2023.
This trader's CIK number is 1769457.
At the time of last reporting, Sullivan Lara was the President and CEO of Pyxis Oncology, Inc.. (stock ticker symbol PYXS).
Also see all insider trading activities at Pyxis Oncology, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | PYXS | 0 | $0 | 36,558 | $81,469 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-09-18 | PYXS | Sale | 8,541 | 2.10 | 17,936 |
| 2023-09-14 | PYXS | Sale | 100 | 2.25 | 225 |
| 2023-09-13 | PYXS | Sale | 3,000 | 2.27 | 6,815 |
| 2023-09-12 | PYXS | Sale | 4,917 | 2.25 | 11,073 |
| 2023-09-11 | PYXS | Sale | 20,000 | 2.27 | 45,420 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Sullivan Lara (President and CEO of Pyxis Oncology, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.